Biosimiliars laboratories may also do the following tests:

Comparative Analytical Characterization: To demonstrate similarity in structure and function to the reference product Testing
Clinical Efficacy and Safety Studies: To confirm that there are no clinically meaningful differences in efficacy and safety Testing
Immunogenicity Testing: To assess the potential for immune response Testing
Pharmacokinetic (PK) and Pharmacodynamic (PD) Studies: To compare the biosimilar's and the reference product's bioavailability and effect on the body Testing
Stability Testing: To ensure product quality over time Testing